Life Sciences

  • One of the world’s leading pharmaceutical companies in contesting the non-reimbursement decision of the Finnish Pharmaceutical Pricing Board pertaining to a key product of the company. After the appeal was lodged in the Finnish Supreme Administrative Court, the Board granted reimbursement status on the basis of a new reimbursement application submitted by the company. 
  • A global pharmaceutical company in a dispute at the Helsinki Administrative Court concerning several marketing authorisations issued by the Finnish National Agency for Medicines to a competitor. 
  • A global pharmaceutical company in several simultaneous and extensive injunction and patent infringement proceedings at the Helsinki District Court. 
  • A Finnish subsidiary of a multi-national diagnostics company in a court dispute on the ownership of a patentable invention. The case is currently pending at the Helsinki District Court. 
  • A leading global biotechnology company manufacturing and supplying biologically derived medications in a public procurement case against a hospital district. A positive outcome was reached without court proceedings and within the regulations governing public procurement. 
  • A leading Finnish biotechnology company in the initial public offering (IPO) of its shares on the Helsinki Stock Exchange. 
  • A leading Finnish drug development company in planning and implementing a merger of three companies active in the biotechnology field. 
  • A major Nordic venture capital firm in conducting a legal and regulatory due diligence investigation, including public policy-related considerations, of a major Finnish healthcare service provider company. 
  • A subsidiary of an international pharmaceutical company in a dispute concerning marketing of prescription medicines. 
  • A global pharmaceutical company in drafting and negotiating a clinical trial agreement, including advice concerning informed concent documents and collecting and storage of personal data as well as transfer of patient-related personal data outside the EU/EEA area. 
  • A leading Finnish pharmaceutical company in negotiating a supply and distribution agreement on an over the counter (OTC) product. 
  • A Finnish biotech start-up in drafting an agreement on research and development collaboration with a major Finnish university. 
  • A Finnish drug discovery company in drafting and negotiating a global patent and know-how license arrangement with a multi-national pharmaceutical company.